LH
Laboratory Corp Of America Holdings (LH)
Healthcare • NYSE • $254.12-1.52%
- Symbol
- LH
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $254.12
- Daily Change
- -1.52%
- Market Cap
- $20.84B
- Trailing P/E
- 22.53
- Forward P/E
- 13.07
- 52W High
- $293.72
- 52W Low
- $239.67
- Analyst Target
- $310.06
- Dividend Yield
- +1.13%
- Beta
- 0.88
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, …
Company websiteResearch LH on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.